HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Modern concept of rehabilitation of patients with vulvar cancer: the main trends and future ways of development

DOI: https://doi.org/10.29296/25877305-2023-10-01

D. Blinov(1–3), Candidate of Medical Sciences; Professor A. Solopova(1), MD; Professor E. Achkasov(1), MD; T. Blbulyan(4); G. Bykovshchenko(1); D. Petrenko(1)
1-I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2-Institute of Preventive and Social Medicine, Moscow
3-F.P. Gaaz Moscow Sociomedical Institute
4-Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia

Vulvar cancer (VC) is a relatively uncommon malignant neoplasm of the female genital system. However, the prevalence of human papillomavirus infection in women of reproductive age has been increasing, elevating the risk of this oncopathology. The treatment of VC, like many other malignant tumors, involves radical approaches that have a profound impact on various aspects of a woman's life. Surgical intervention significantly alters the anatomy of the external genitalia, leading to serious psycho-emotional disorders such as anxiety, depression, and body image dissatisfaction. Additionally, common adverse effects of treatment include lower extremity lymphedema, sexual dysfunction, and social maladjustment, all of which contribute to a reduced overall quality of life (QoL). To address these complications and enhance the QoL for patients following radical surgical treatment of VC, it is essential to timely introduce comprehensive personalized rehabilitation into the management strategy.

vulvar cancer
quality of life

  1. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71 (3): 209–49. DOI: 10.3322/caac.21660
  2. Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. DOI: 10.1038/s41571-021-00514-z
  3. Cостояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022; 239 с. [The state of oncological care for the Russian population in 2021. Eds. A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: Hertsen Moscow Oncology Research Center – Branch of National Medical Research Radiological Centre, 2022; 239 p. (in Russ.)].
  4. Клинические рекомендации: рак вульвы. 2020 [Clinical guideline: Vulvar cancer. 2020 (in Russ.)]. URL: https://cr.minzdrav.gov.ru/schema/501_1
  5. Tan A., Bieber A.K., Stein J.A. et al. Diagnosis and management of vulvar cancer: A review. J Am Acad Dermatol. 2019; 81 (6): 1387–96. DOI: 10.1016/j.jaad.2019.07.055
  6. Malandrone F., Bevilacqua F., Merola M. et al. The Impact of Vulvar Cancer on Psychosocial and Sexual Functioning: A Literature Review. Cancers. 2021; 14 (1): 63. DOI: 10.3390/cancers14010063
  7. Zhu H. Squamous Cell Carcinoma Antigen: Clinical Application and Research Status. Diagnostics (Basel). 2022; 12 (5): 1065. DOI: 10.3390/diagnostics12051065
  8. Сулейманова Н.Д. Факторы риска злокачественных новообразований женских половых органов. Вестник новых медицинских технологий. 2014; 21 (1): 15–21 [Suleimanova N.D. Risk factors of malignant neoplasms of female genital organs (review of literature). Journal of New Medical Technologies. 2014; 21 (1): 15–21 (in Russ.)]. DOI: 10.12737/3326
  9. Merlo S. Modern treatment of vulvar cancer. Radiol Oncol. 2020; 54 (4): 371–6. DOI: 10.2478/raon-2020-0053
  10. Pedrão P.G., Guimarães Y.M., Godoy L.R. et al. Management of Early-Stage Vulvar Cancer. Cancers (Basel). 2022; 14 (17): 4184. DOI: 10.3390/cancers14174184
  11. Collarino A., Fuoco V., Garganese G. et al. Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel. Eur J Nucl Med Mol Imaging. 2020; 47 (5): 1261–74. DOI: 10.1007/s00259-019-04650-8
  12. Блинов Д.В., Солопова А.Г., Плутницкий А.Н. и др. Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022; 15 (1): 119–30 [Blinov D.V., Solopova A.G., Plutnitskiy A.N. et al. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022; 15 (1): 119–30 (in Russ.)]. DOI: 10.17749/2070-4909/farmakoekonomika.2022.132
  13. Seland M., Skrede K., Lindemann K. et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022; 101 (3): 313–22. DOI: 10.1111/aogs.14310
  14. Carter J., Huang H.Q., Armer J. et al. GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol Oncol. 2021; 160 (1): 244–51. DOI: 10.1016/j.ygyno.2020.10.023
  15. Biglia N., Zanfagnin V., Daniele A. et al. Lower Body Lymphedema in Patients with Gynecologic Cancer. Anticancer Res. 2017; 37 (8): 4005–15. DOI: 10.21873/anticanres.11785
  16. Gaarenstroom K.N., Kenter G.G.., Trimbos J.B. et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003; 13 (4): 522–7. DOI: 10.1046/j.1525-1438.2003.13304.x
  17. Gould N., Kamelle S., Tillmanns T. et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol. 2001; 82 (2): 329–32. DOI: 10.1006/gyno.2001.6266
  18. Sullivan S.A., Van Le L., Liberty A.L. et al. Association between hypoalbuminemia and surgical site infection in vulvar cancers. Gynecol Oncol. 2016; 142 (3): 435–9. DOI: 10.1016/j.ygyno.2016.06.021
  19. Martin A.L., Stewart J.R., Girithara-Gopalan H. et al. Trends and Complications of Vulvar Reconstruction After Vulvectomy: A Study of a Nationwide Cohort. Int J Gynecol Cancer. 2018; 28 (8): 1606–15. DOI: 10.1097/IGC.0000000000001332
  20. Di Donato V., Bracchi C., Cigna E. et al. Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: Evaluation of feasibility and morbidity of different surgical techniques. Surg Oncol. 2017; 26 (4): 511–21. DOI: 10.1016/j.suronc.2017.10.002
  21. Levine M.D., Felix A.S., Meade C.E. et al. The modified 5-item frailty index is a predictor of post-operative complications in vulvar cancer: a National Surgical Quality Improvement Program (NSQIP) analysis. Int J Gynecol Cancer. 2023; 33 (4): 465–72. DOI: 10.1136/ijgc-2022-004175
  22. Senn B., Eicher M., Mueller M.D. et al. A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecol Oncol. 2013; 129 (1): 234–40. DOI: 10.1016/j.ygyno.2012.12.038
  23. Günther V., Malchow B., Schubert M. et al. Impact of radical operative treatment on the quality of life in women with vulvar cancer--a retrospective study. Eur J Surg Oncol. 2014; 40 (7): 875–82. DOI: 10.1016/j.ejso.2014.03.027
  24. Barlow E.L., Hacker N.F., Hussain R. et al. Sexuality and body image following treatment for early-stage vulvar cancer: a qualitative study. J Adv Nurs. 2014; 70 (8): 1856–66. DOI: 10.1111/jan.12346
  25. Aerts L., Enzlin P., Verhaeghe J. et al. Psychologic, relational, and sexual functioning in women after surgical treatment of vulvar malignancy: a prospective controlled study. Int J Gynecol Cancer. 2014; 24 (2): 372–80. DOI: 10.1097/IGC.0000000000000035
  26. Avery W., Gardner C., Palmer S. Vulvectomy. Am J Nurs. 1974; 74 (3): 453–5.
  27. Boden J., Willis S. The psychosocial issues of women with cancer of the vulva. J Radiother Pract. 2019; 18: 93–7. DOI: 10.1017/S1460396918000420
  28. Senn B., Gafner D., Happ M.B. et al. The unspoken disease: symptom experience in women with vulval neoplasia and surgical treatment: a qualitative study. Eur J Cancer Care (Engl). 2011; 20 (6): 747–58. DOI: 10.1111/j.1365-2354.2011.01267.x
  29. McGrath P., Rawson N. Key factors impacting on diagnosis and treatment for vulvar cancer for Indigenous women: findings from Australia. Support Care Cancer. 2013; 21 (10): 2769–75. DOI: 10.1007/s00520-013-1859-7
  30. Блбулян Т.А., Солопова А.Г., Иванов А.Е. и др. Влияние послеоперационной реабилитации на качество жизни больных раком вульвы. Акушерство, Гинекология и Репродукция. 2020; 14 (4): 415–25 [Blbulyan T.A., Solopova A.G., Ivanov A.E. et al. Effect of postoperative rehabilitation on quality of life in patients with vulvar cancer. Obstetrics, Gynecology and Reproduction. 2020; 14 (4): 415–25 (in Russ.)]. DOI: 10.17749/2313-7347/ob.gyn.rep.2020.156
  31. Tounkel I., Nalubola S., Schulz A. et al. Sexual Health Screening for Gynecologic and Breast Cancer Survivors: A Review and Critical Analysis of Validated Screening Tools. Sex Med. 2022; 10 (2): 100498. DOI: 10.1016/j.esxm.2022.100498
  32. Wiegel M., Meston C., Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005; 31 (1): 1–20. DOI: 10.1080/00926230590475206
  33. Rothmund M., Pilz M.J., Egeter N. et al. Patient-reported outcome measures for emotional functioning in cancer patients: Content comparison of the EORTC CAT Core, FACT-G, HADS, SF-36, PRO-CTCAE, and PROMIS instruments. Psychooncology. 2023; 32 (4): 628–39. DOI: 10.1002/pon.6109
  34. Novackova M., Halaska M.J., Robova H. et al. A Prospective Study in the Evaluation of Quality of Life After Vulvar Cancer Surgery. Int J Gynecol Cancer. 2015; 25 (1): 166–73. DOI: 10.1097/IGC.0000000000000313
  35. de Melo Ferreira A.P., de Figueiredo .E.M., Lima R.A. et al. Quality of life in women with vulvar cancer submitted to surgical treatment: a comparative study. Eur J Obstet Gynecol Reprod Biol. 2012; 165 (1): 91–5. DOI: 10.1016/j.ejogrb.2012.06.027
  36. Janda M., Obermair A., Cella D. et al. Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer. 2004; 14 (5): 875–81. DOI: 10.1111/j.1048-891X.2004.14524.x
  37. Власина А.Ю., Солопова А.Г., Иванова Е.А. и др. «Противораковая диета», или принципы рационального питания онкогинекологических больных в период реабилитации. Врач. 2020; 31 (4): 3–7 [Vlasina A., Solopova A., Ivanova E. et al. Anticancer diet, or principles of rational nutrition in gynecological cancer patients during rehabilitation. Vrach. 2020; 31 (4): 3–7 (in Russ.)]. DOI: 10.29296/25877305-2020-04-01
  38. Huang Y.C., Chang K.V. Kegel Exercises. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023.
  39. Rose G.L., Stewart E.M., Clifford B.K. et al. Efficacy of exercise interventions for women during and after gynaecological cancer treatment - a systematic scoping review. Support Care Cancer. 2023; 31 (6): 342. DOI: 10.1007/s00520-023-07790-8
  40. Wagner B., Steiner M., Huber D.F.X. et al. The effect of biofeedback interventions on pain, overall symptoms, quality of life and physiological parameters in patients with pelvic pain: A systematic review. Wien Klin Wochenschr. 2022; 134 (Suppl 1): 11–48. DOI: 10.1007/s00508-021-01827-w
  41. Wu X., Zheng X., Yi X. et al. Electromyographic Biofeedback for Stress Urinary Incontinence or Pelvic Floor Dysfunction in Women: A Systematic Review and Meta-Analysis. Adv Ther. 2021; 38 (8): 4163–77. DOI: 10.1007/s12325-021-01831-6
  42. Cross D., Waheed N., Krake M. et al. Effectiveness of supervised Kegel exercises using bio-feedback versus unsupervised Kegel exercises on stress urinary incontinence: a quasi-experimental study. Int Urogynecol J. 2023; 34 (4): 913–20. DOI: 10.1007/s00192-022-05281-8
  43. Озолиня Л.А., Савченко Т.Н., Анисимова М.А. роль современных методов физиотерапии в профилактике и лечении гинекологических заболеваний (обзор литературы). Архив акушерства и гинекологии им. В.Ф. Снегирева. 2019; 6 (3): 121–7 [Ozolinya L.A., Savchenko T.N., Anisimova M.A. The role of modern physiotherapy in the prevention and treatment of gynecological diseases (review of literature). V.F. Snegirev Archives of Obstetrics and Gynecology. 2019; 6 (3): 121–7 (in Russ.)]. DOI: 10.18821/2313-8726-2019-6-3-121-127
  44. Monteiro M.G.C.T., de Morais Gouveia G.P. Physiotherapy in the management of gynecological cancer patient: A systematic review. J Bodyw Mov Ther. 2021; 28: 354–61. DOI: 10.1016/j.jbmt.2021.06.027
  45. Солопова А.Г., Блинов Д.В., Демьянов С.В. и др. Эпигенетические аспекты реабилитации онкогинекологических больных. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022; 15 (2): 294–303 [Solopova A.G., Blinov D.V., Demyanov S.V. et al. Epigenetic aspects in rehabilitation of female cancer patients. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022; 15 (2): 294–303 (in Russ.)]. DOI: 10.17749/2070-4909/farmakoekonomika.2022.141
  46. Krychman M., Graham S., Bernick B. et al. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. J Sex Med. 2017; 14 (3): 425–33. DOI: 10.1016/j.jsxm.2017.01.011
  47. Солопова А.Г., Идрисова Л.Э., Макацария А.Д. и др. Мультидисциплинарный подход к медицинской реабилитации онкогинекологических больных. Акушерство, Гинекология и Репродукция. 2017; 11 (4): 57–67 [Solopova A.G., Idrisova L.E., Makatsariya A.D. et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients. Obstetrics, gynecology and reproduction. 2017; 11 (4): 57–67 (in Russ.)]. DOI: 10.17749/2313-7347.2017.11.4.057-067